[New hypotensive drugs].
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004151:Dipeptides / Q000627:therapeutic use; D004341:Drug Evaluation; D004656:Enalapril; D015736:Felodipine; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007190:Indapamide / Q000627:therapeutic use; D007217:Indoramin / Q000627:therapeutic use; D007650:Ketanserin; D009543:Nifedipine / Q000031:analogs & derivatives / Q000627:therapeutic use; D009568:Nitrendipine; D010879:Piperazines / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011224:Prazosin / Q000031:analogs & derivatives / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004151:Dipeptides; D010879:Piperazines; D010880:Piperidines; D007217:Indoramin; C005185:trimazosin; D004656:Enalapril; D007650:Ketanserin; D009568:Nitrendipine; D007190:Indapamide; C019578:tiodazosin; D009543:Nifedipine; D015736:Felodipine; D011224:Prazosin
Nowe leki hipotensyjne.